Michael J. Foster - May 31, 2023 Form 4 Insider Report for Sabra Health Care REIT, Inc. (SBRA)

Role: Director
Signature: /s/ Michael Costa, as Attorney-in-Fact
Stock symbol: SBRA
Transactions as of: May 31, 2023
Transactions value $: $0
Form type: 4
Date filed: 6/2/2023, 05:25 PM
Previous filing: Mar 2, 2023
Next filing: Jun 16, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SBRA	Common Stock	Award	$0	+1.09K	+1.87%	$0.00	59.4K	May 31, 2023	Direct	F1, F2
holding	SBRA	Common Stock						42.5K	May 31, 2023	401(k) Plan

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
F2	Includes 804 unvested stock units and 41,330 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Content

Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

Includes 804 unvested stock units and 41,330 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.